CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to revolutionize tuberculosis drug development by repurposing existing drugs and targeting energy metabolism pathways. By employing innovative strategies, it seeks to address the challenges of drug resistance and improve treatment outcomes for tuberculosis.
Tuberculosis is one of the most worrying Global and Public Health problems in the present day and causes a major economic and social burden, which can significantly drain a society’s resources.
In 2015, 10.4 million people fell ill with tuberculosis and 1.8 million died from the disease.
In addition, an estimated 480000 people developed multidrug-resistant tuberculosis.
The development of new drugs and new therapeutic regimens effective against drug susceptible and drug resistant tuberculosis i…
UNIVERSIDADE NOVA DE LISBOA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
